Text Size
S
M
L
Listen
Santen Global
menu
Patients
Healthcare Professionals
Careers
Investors
Listen
Tap on the left to use.
Who We Are
Message
Message from the CEO
Corporate Story
Corporate Story
CORE PRINCIPLE / Our Commitment
CORE PRINCIPLE / Our Commitment
Our Values
Our Values
History
History of Santen
Corporate Executives
Corporate Executives
Corporate Governance
Corporate Governance
Policies
Policies and Statements
Company Infomation
Overview / Map
Global Operation
What We Do
MTP & Santen 2030
Medium-term Management Plan
Santen 2030
Efforts to Enhance Patients' Satisfaction
Efforts to Enhance Product Safety
Efforts to Enhance Product Usability
Efforts to Address Untreated Patients
Research & Development
Research & Development
The Ophthalmic Product Process: R&D
Clinical Trial Information
Partnering
Santen's Partnership
Our Partners
Partnering Contact
Production
Production
Safety and Quality Assurance
The Ophthalmic Production Process: Production
Sales & Marketing
Sales & Marketing
Our Stories
Sustainability
Sustainability
Our Sustainability Commitment
Sustainability at Santen
Social
Access to Healthcare
Research & Development in Ophthalmology
Product Quality & Safety
Supply Chain
Human Rights
Talent
Digital Transformation (DX)
Governance
Corporate Governance
Compliance
Ethical Marketing
Risk Management
Information Security
Environment
Environmental initiatives
Measures against Climate Change
Environmental Load Reduction
Biodiversity
Disclosures Based on the TCFD Recommendations
Inclusion
Inclusive Society Santen Promotes
Inclusion Starting from Blind Football
Together with Society
With Employees
Related Information
Participating in the UN Global Compact
Social Contribution Activities
Stakeholder Engagement
Environment Data (up-to-date)
Social Data (up-to-date)
Governance Data (up-to-date)
GRI Standards Content Index
Sustainability Library
External Assessment
News
News
Show All
Press Release
IR News
Information
HOME
News
2020
Press Release
2020 Press Release
RSS
Press Release
11.05.2020
Santen releases LENTIS Comfort Toric in Japan, a multifocal IOL covered under the Japanese health insurance program for cataract patients with astigmatism
10.28.2020
Santen, JBFA and IBF Foundation Form Long-term Partnership for an Inclusive Society ~An innovative, 10-year partnership agreement that aims to achieve long-term stability of sports management for the advancement of diversity and inclusion in our society~
10.28.2020
Santen and Aerie Conclude Exclusive License Agreement for Rhopressa and Rocklatan in Japan and Several Other Asian Countries
10.08.2020
Santen and Orbis International Announce Long-term Partnership to Tackle the Increasing Burden of Eye Diseases
09.17.2020
Santen and U.S. Ophthalmic Company Eyevance Enters into Share Purchase Agreement
09.15.2020
Notice of Corporate Officer Appointments
09.10.2020
~Building an Inclusive Society~Santen Decides to Offer Special Sponsorship for Continued Activities of Men's and Women's National Blind Football Teams
08.11.2020
~Building an Inclusive Society~Santen and International Blind Sports Federation Forges Partnership through Blind Sports
07.28.2020
Santen and RVL Pharmaceuticals, Inc., an Osmotica Company, Enter into an Exclusive License Agreement in Japan, Asia, and EMEA for RVL-1201, a First-in-Class Treatment for Acquired Blepharoptosis
03.05.2020
Santen to Conduct Activities to Raise Awareness on Importance of Early Detection and Treatment of Glaucoma during World Glaucoma Week (March 8-14, 2020)
02.18.2020
Notice of personnel change
News Archive
